A Singapore research team of clinicians and scientists has validated a cancer diagnostic assay designed with Asian-centric biomarkers that aims to enable early diagnosis and timely treatment delivery.

Cerebrospinal fluid (CSF)-based molecular tests can reliably distinguish multiple sclerosis (MS) from other neurological conditions, according to a new study that analyzed cryopreserved CSF samples ...

The FDA has expanded the approval of Hologic’s Aptima human papillomavirus (HPV) assay for clinician-collected primary ...

Dublin, Jan. 14, 2026 (GLOBE NEWSWIRE) -- The "Sepsis Diagnostics Market 2025-2029 - Global Market Forecasts by Assay, Cause, Product, Lab and Place, with Executive and Consultant Guides" has been ...

Papakostas G.I., Shelton R.C., Kinrys G., Henry M.E., Bakow B.R., Lipkin S.H., Pi B., Thurmond L., Bilello J.A. Assessment of a multi-assay, serum-based biological ...

The availability of a four-in-one respiratory virus diagnostic for home use may be a boon to consumers, but some clinicians say it should not be used as a substitute for a physician’s guidance.

The Molecular Diagnostic and Assay Development Hub is focused on expanding our targeted and agnostic diagnostic capabilities against viral threats with pandemic potential. During the two-year start-up ...

A salivary miRNA test for endometriosis shows high accuracy; however, experts debate whether it can replace laparoscopy.

The study has shown that a cancer diagnostic assay designed with Asian-centric biomarkers is safe and precise and can can measure 4 major classes of biomarkers, allowing for molecular characterisation ...